Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Home workouts aim to stop falls in blood cancer patients

NCT ID NCT07044427

First seen Jan 25, 2026 · Last updated Jun 22, 2026 · Updated 20 times

Summary

This study looks at why multiple myeloma patients fall and tests a personalized home exercise program to prevent falls. Sixty patients will do strength and balance exercises three times a week for six months, plus treadmill training. The goal is to see if the program is practical and reduces fear of falling.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Heidelberg

    RECRUITING

    Heidelberg, Baden Würtemberg, 69120, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Strength and balance training plus treadmill-based perturbation training

What this could lead to

If successful, this could provide a simple, home-based exercise program to reduce falls and improve quality of life for multiple myeloma patients.

What could go wrong

This is a small, early feasibility study with only 60 participants. The exercise program may be too demanding for some patients, and results may not apply to all.

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.